![Ovarian Cancer: Post-Relapse Survival and Prognostic Factors | Miyoshi | Journal of Clinical Gynecology and Obstetrics Ovarian Cancer: Post-Relapse Survival and Prognostic Factors | Miyoshi | Journal of Clinical Gynecology and Obstetrics](https://www.jcgo.org/tables/jcgo488w-g002.jpg)
Ovarian Cancer: Post-Relapse Survival and Prognostic Factors | Miyoshi | Journal of Clinical Gynecology and Obstetrics
![Researchers Create Tool to Help Predict Survival for Patients with Advanced Stage Recurrent Ovarian Cancer – Consult QD Researchers Create Tool to Help Predict Survival for Patients with Advanced Stage Recurrent Ovarian Cancer – Consult QD](https://consultqd.clevelandclinic.org/wp-content/uploads/sites/2/2019/03/Ovarian-CA_650x450.jpg)
Researchers Create Tool to Help Predict Survival for Patients with Advanced Stage Recurrent Ovarian Cancer – Consult QD
![Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort | British Journal of Cancer Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2011.328/MediaObjects/41416_2011_Article_BFbjc2011328_Fig1_HTML.jpg)
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort | British Journal of Cancer
![Frontiers | Successful Treatment of a Patient With Brain Metastasis From Ovarian Cancer With BRCA Wild Type Using Niraparib: A Case Report and Review of the Literature Frontiers | Successful Treatment of a Patient With Brain Metastasis From Ovarian Cancer With BRCA Wild Type Using Niraparib: A Case Report and Review of the Literature](https://www.frontiersin.org/files/MyHome%20Article%20Library/873198/873198_Thumb_400.jpg)
Frontiers | Successful Treatment of a Patient With Brain Metastasis From Ovarian Cancer With BRCA Wild Type Using Niraparib: A Case Report and Review of the Literature
![Ovarian Cancer Patient | Sara's Story: Getting Through Surgery, Chemo, PARP Inhibitor (Video 2/3) - YouTube Ovarian Cancer Patient | Sara's Story: Getting Through Surgery, Chemo, PARP Inhibitor (Video 2/3) - YouTube](https://i.ytimg.com/vi/pFpYhx8AOnc/maxresdefault.jpg)
Ovarian Cancer Patient | Sara's Story: Getting Through Surgery, Chemo, PARP Inhibitor (Video 2/3) - YouTube
![Ovarian Cancer: Post-Relapse Survival and Prognostic Factors | Miyoshi | Journal of Clinical Gynecology and Obstetrics Ovarian Cancer: Post-Relapse Survival and Prognostic Factors | Miyoshi | Journal of Clinical Gynecology and Obstetrics](https://www.jcgo.org/tables/jcgo488w-g003.jpg)
Ovarian Cancer: Post-Relapse Survival and Prognostic Factors | Miyoshi | Journal of Clinical Gynecology and Obstetrics
![Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort | British Journal of Cancer Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fbjc.2011.328/MediaObjects/41416_2011_Article_BFbjc2011328_Fig2_HTML.jpg)
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort | British Journal of Cancer
![Never Losing Hope: Ovarian cancer survivor shares her story | Magee-Womens Research Institute & Foundation Never Losing Hope: Ovarian cancer survivor shares her story | Magee-Womens Research Institute & Foundation](https://mageewomens.org/assets/images/headlines/_fullWidthContentImageMobi/jan.jpg)
Never Losing Hope: Ovarian cancer survivor shares her story | Magee-Womens Research Institute & Foundation
![Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network Prediction of candidate RNA signatures for recurrent ovarian cancer prognosis by the construction of an integrated competing endogenous RNA network](https://www.spandidos-publications.com/article_images/or/40/5/OR-40-05-2659-g06.jpg)